Medicare Advantage insurers mull Wegovy coverage ‘trade-offs’
CMS lifted the coverage prohibition on weight loss drug Wegovy for some Medicare enrollees last month. Here’s how insurers are considering their options.
CMS lifted the coverage prohibition on weight loss drug Wegovy for some Medicare enrollees last month. Here’s how insurers are considering their options.
Hims & Hers co-founder and CEO Andrew Dudum used the company’s first-quarter earnings call to clarify a recent social media post regarding protests against the…
Here is what five telehealth executives and investors had to say about Walmart and others exiting virtual care.
In this interview, Browning discusses his team’s trial data and the implications of the FDA’s decision to accept the supplemental new drug application for tapinarof…
Of the more than 1,000 residents at UChicago Medicine, 98% voted to join a division of the Service Employees International Union.
STAT Breakthrough Summit West is one-day event designed to break down silos across health and medicine by bringing together leaders, entrepreneurs, policymakers, patient advocates —…
The April 2024 cardiology month in review spotlights FDA news and top updates from the American College of Cardiology 2024 Scientific Session.
The U.S. FDA’s panel of independent advisers will on June 4 deliberate whether they should recommend approval for the first MDMA-assisted therapy for post-traumatic stress…
AUA 2024 comparison of mitomycin C vs BCG treatment, non-muscle invasive bladder cancer, International Bladder Cancer Group (IBCG), Kaplan-Meier analysis.
Latticework Capital Management said it exceeded its goal for its second healthcare fund.
Indian generic drugmaker Lupin reported a smaller-than-expected rise in fourth-quarter profit on Monday, as higher raw material costs more than offset strong demand for its…